X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SANOFI INDIA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SANOFI INDIA ABBOTT INDIA/
SANOFI INDIA
 
P/E (TTM) x 39.7 32.0 124.2% View Chart
P/BV x 10.6 5.6 187.6% View Chart
Dividend Yield % 0.7 1.5 42.2%  

Financials

 ABBOTT INDIA   SANOFI INDIA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
SANOFI INDIA
Dec-18
ABBOTT INDIA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs6,1106,840 89.3%   
Low Rs3,9964,630 86.3%   
Sales per share (Unadj.) Rs1,552.21,203.1 129.0%  
Earnings per share (Unadj.) Rs188.8165.3 114.2%  
Cash flow per share (Unadj.) Rs196.4209.9 93.6%  
Dividends per share (Unadj.) Rs55.0084.00 65.5%  
Dividend yield (eoy) %1.11.5 74.3%  
Book value per share (Unadj.) Rs796.6963.6 82.7%  
Shares outstanding (eoy) m21.2523.03 92.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.34.8 68.3%   
Avg P/E ratio x26.834.7 77.1%  
P/CF ratio (eoy) x25.727.3 94.1%  
Price / Book Value ratio x6.36.0 106.6%  
Dividend payout %29.150.8 57.3%   
Avg Mkt Cap Rs m107,376132,078 81.3%   
No. of employees `0003.33.3 100.6%   
Total wages/salary Rs m3,9374,068 96.8%   
Avg. sales/employee Rs Th9,929.38,393.8 118.3%   
Avg. wages/employee Rs Th1,185.11,232.4 96.2%   
Avg. net profit/employee Rs Th1,207.71,153.0 104.7%   
INCOME DATA
Net Sales Rs m32,98527,708 119.0%  
Other income Rs m1,170897 130.4%   
Total revenues Rs m34,15528,605 119.4%   
Gross profit Rs m5,2456,235 84.1%  
Depreciation Rs m1621,027 15.8%   
Interest Rs m387 545.7%   
Profit before tax Rs m6,2156,098 101.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2032,292 96.1%   
Profit after tax Rs m4,0123,806 105.4%  
Gross profit margin %15.922.5 70.7%  
Effective tax rate %35.437.6 94.3%   
Net profit margin %12.213.7 88.6%  
BALANCE SHEET DATA
Current assets Rs m22,65515,922 142.3%   
Current liabilities Rs m6,6816,235 107.1%   
Net working cap to sales %48.435.0 138.5%  
Current ratio x3.42.6 132.8%  
Inventory Days Days6564 101.8%  
Debtors Days Days2921 139.7%  
Net fixed assets Rs m8357,539 11.1%   
Share capital Rs m213230 92.4%   
"Free" reserves Rs m16,71521,962 76.1%   
Net worth Rs m16,92822,192 76.3%   
Long term debt Rs m00-   
Total assets Rs m24,16229,839 81.0%  
Interest coverage x163.7872.1 18.8%   
Debt to equity ratio x00-  
Sales to assets ratio x1.40.9 147.0%   
Return on assets %16.812.8 131.2%  
Return on equity %23.717.2 138.2%  
Return on capital %36.927.5 134.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3697,587 4.9%   
Fx outflow Rs m3,8077,145 53.3%   
Net fx Rs m-3,438442 -777.8%   
CASH FLOW
From Operations Rs m1,5273,739 40.8%  
From Investments Rs m-2,148-731 293.9%  
From Financial Activity Rs m-1,024-1,972 51.9%  
Net Cashflow Rs m-1,6461,036 -158.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 60.4 124.2%  
Indian inst/Mut Fund % 7.9 14.4 54.9%  
FIIs % 0.1 14.6 0.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 10.5 162.9%  
Shareholders   18,270 15,184 120.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   BIOCON   CADILA HEALTHCARE  SUVEN LIFESCIENCES  PLETHICO PHARMA  WOCKHARDT  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End on a Strong Note; Sensex Ends 489 Points Higher(Closing)

After opening the day marginally lower, Indian share markets witnessed most of the buying interest during closing hours and ended their trading session on a strong note.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jun 20, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - ASTRAZENECA PHARMA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS